| |
|
|
|
Avadel Pharmaceuticals plc  
|
|
2.33 0.16 (0.07%) |
08-23 16:00 |
|
Open: |
2.15 |
Pre close: |
2.17 |
Target:
|
3.04 
|
|
High: |
2.39 |
Low: |
2.15 |
Resistance:
|
2.60
3.04
|
|
Volume: |
347,038 |
Market Cap: |
87M |
Support:
|
2.12
1.82
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.14
|
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
2.14  |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
1.92 |
Stochastic Oscillator |
%K(14,3):
|
69.44 |
|
MA(250): |
2.63 |
%D(3): |
52.64 |
|
Average Volume(K) |
3-Month: |
29306
|
52-Week |
High:
|
5.25 |
|
10-Days: |
18034 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
57.58 |
Change(%): |
-46.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.724 |
Return on Equity (ttm) |
-333.2 |
Shares Out. (M) |
37.36 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-11.8 |
Shares Float (M) |
27.29 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.21 |
% Held by Insiders |
2.74 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-39.9 |
% Held by Institutions |
55.90 |
|
Forward EPS |
-0.060 |
Gross Profit (p.s.) |
2.295 |
Shares Short (K) |
5950 |
|
Book Value (p.s.) |
-0.480 |
EBITDA (p.s.) |
-1.040 |
P/E |
-0.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.85 |
|
Profit Margin |
-135.48 |
Operating Cash Flow
(M) |
-67.43 |
P/S |
43307860.00 |
|
Operating Margin |
-58.28 |
Levered Free Cash Flow
(M) |
-29.75 |
P/CF |
-1.29 |
|
|
|
|
|
|
